DXB Ann: FDA IND Approval for Phase 3 Study of DMX-200 in FSGS - 9th May 2022, 9:14am

[annb0t]

DXB Ann: FDA IND Approval for Phase 3 Study of DMX-200 in FSGS
Price Sensitive: Y
Date: 9th May 2022, 9:14am

>>> Read announcement: Google: DXB Market Announcements